Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Markman

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
BMJ Open|July 20, 2017
Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendationsJennifer S Gewandter, Michael P McDermott, Rachel A Kitt, et al.
Journal of Pain Research|November 16, 2017
The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health surveyMarco D DiBonaventura, Alesia Sadosky, Kristen Concialdi, et al.
The Journal of Pain|August 25, 2016
Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint StudyShannon M Smith, Jennifer S Gewandter, Rachel A Kitt, et al.
Regional Anesthesia and Pain Medicine|November 14, 2023
Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomesMahd Nishtar, Remington Mark, Dale J Langford, et al.
Spine|February 24, 2015
A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal StenosisJohn D Markman, Jennifer S Gewandter, Maria E Frazer, et al.
Journal of Pain Research|January 22, 2019
Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician examIan Kudel, Markay Hopps, Joseph C Cappelleri, et al.
Pain|May 27, 2020
Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safetyJohn D Markman, Robert B Bolash, Timothy E McAlindon, et al.
Pain Reports|February 6, 2023
Real-world data and evidence in pain research: a qualitative systematic review of methods in current practiceJan Vollert, Bethea A Kleykamp, John T Farrar, et al.
Pain|September 2, 2025
Real-world data and evidence in pain research: an IMMPACT comprehensive review and best practice recommendationsJan Vollert, John Spivack, Blythe Adamson, et al.
Pain|July 13, 2018
Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysisKushang V Patel, Robert Allen, Laurie Burke, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
BMJ Open|July 20, 2017
Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendationsJennifer S Gewandter, Michael P McDermott, Rachel A Kitt, et al.
Journal of Pain Research|November 16, 2017
The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health surveyMarco D DiBonaventura, Alesia Sadosky, Kristen Concialdi, et al.
The Journal of Pain|August 25, 2016
Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint StudyShannon M Smith, Jennifer S Gewandter, Rachel A Kitt, et al.
Regional Anesthesia and Pain Medicine|November 14, 2023
Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomesMahd Nishtar, Remington Mark, Dale J Langford, et al.
Spine|February 24, 2015
A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal StenosisJohn D Markman, Jennifer S Gewandter, Maria E Frazer, et al.
Journal of Pain Research|January 22, 2019
Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician examIan Kudel, Markay Hopps, Joseph C Cappelleri, et al.
Pain|May 27, 2020
Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safetyJohn D Markman, Robert B Bolash, Timothy E McAlindon, et al.
Pain Reports|February 6, 2023
Real-world data and evidence in pain research: a qualitative systematic review of methods in current practiceJan Vollert, Bethea A Kleykamp, John T Farrar, et al.
Pain|September 2, 2025
Real-world data and evidence in pain research: an IMMPACT comprehensive review and best practice recommendationsJan Vollert, John Spivack, Blythe Adamson, et al.
Pain|July 13, 2018
Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysisKushang V Patel, Robert Allen, Laurie Burke, et al.
Pageof 6